Dehydroepiandrosterone has been demonstrated to be a better predictor of abnormal anthropometric and biochemical parameters in women with PCOS than DHEAS, particularly in hyperandrogenemic women. This evidence concerns the gene SULT2A1 and polycystic ovary syndrome.